FOLH1 and posterior cortical atrophy: 68Ga-prostate-specific membrane antigen targeted radiopharmaceuticals, which are designed to recognize a membrane glycoprotein that is highly expressed in human PCa cells, have also emerged as having tremendous potential for the detection and re-staging of PCa after biochemical recurrence, offering superior contrast and sensitivity than 18F-choline [4].